The Department of Cancer Imaging and Metabolism (CIM) is focused on the use of non-destructive techniques to monitor cancers and their environments in their native state. The data from such studies are used to inform mathematical models (in collaboration with the Department of Integrated Mathematical Oncology) to develop new paradigms for carcinogenesis and its treatment.
Examples of research areas include “radiomics” which converts patient images into mineable data for improved prognosis and prediction, “metabolomics” which seeks to identify novel metabolic phenotypes of cancer for illumination of novel therapeutic strategies, and “tumor physiology” which seeks to quantitatively describe the physiological microenvironment that influences carcinogenesis and its response to therapy. This work is being undertaken in human patients as well as in animal models. A significant impact of CIM is the offering of improved quality for both clinical radiology and pathology. CIM faculty members actively collaborate with faculty members throughout Moffitt as well as throughout the world.
Cancer Imaging and Metabolism Department Members
Robert J. Gillies, PhD